Precigen, Inc.

PGEN Stock Healthcare Biotechnology
$6.38
-0.81 (-11.26%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-18.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-25.4%

Own PGEN?

See how PGEN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.